⌘K

Home/Filings/4/0001469709-13-000586

4//SEC Filing

Entia Biosciences, Inc. 4

Accession 0001469709-13-000586

CIK 0001408299operating

View on SEC.gov Company Profile

Filed

Oct 16, 8:00 PM ET

Accepted

Oct 17, 5:57 PM ET

Size

7.6 KB

Accession

0001469709-13-000586

Insider Transaction Report

Form 4

Period: 2013-07-11

Entia Biosciences, Inc.ERGO

ANDRES DEVIN D.

Vice President Sales Marketing

Transactions

Award
Incentive Stock Options
2013-07-11$0.45/sh+150,000$67,500→ 150,000 total
Exercise: $0.45From: 2013-07-11Exp: 2020-07-10→ Common Stock (150,000 underlying)
Award
Common Stock Purchase Warrant
2013-07-11$0.45/sh+150,000$67,500→ 150,000 total
Exercise: $0.45From: 2013-07-11Exp: 2020-07-10→ Common Stock (150,000 underlying)

Footnotes (1)

[F1]The incentive stock options vest immediately.

Documents

1 file

4
ergo-andres4_101713apg.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Entia Biosciences, Inc.

CIK 0001408299

Entity typeoperating

IncorporatedNV

Related Parties

1

filerCIK 0001408299

Filing Metadata

Form type: 4
Filed: Oct 16, 8:00 PM ET
Accepted: Oct 17, 5:57 PM ET
Size: 7.6 KB

View on SEC.gov